ClinicalTrials.govpublic full text
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
allergy, peanut, peanut hypersensitivity, epicutaneous immunotherapy (epit), epicutaneous, immunotherapy, viaskin, nut and peanut hypersensitivity, food hypersensitivity, peanut allergy, food allergy, nut and peanut allergy, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 876723
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.